Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Accenture Plc (ACN): Is This IT Company’s Recent Pullback a Buying Opportunity?

Page 1 of 2

Accenture Plc (NYSE:ACN) recently reported disappointing results thanks to the drop in its consultancy revenue, which offset a healthy increase in its outsourcing business. Its clients are demanding longer horizon consultancy work, so revenue realization is slow in the company’s consultancy business. On the other hand, the company’s outsourcing revenue increased due to the higher demand of outsourcing services. The company is also benefiting from the investment it had made in cloud computing, analytics and mobile platforms. In addition to these factors, the U.S. immigration bill, if passed, will give a competitive advantage to Accenture Plc (NYSE:ACN) over its Indian IT peers. Below, I will discuss these points in detail.

Accenture Plc (NYSE:ACN)

The change in regulations in BFSI will boost revenue

The change in the regulatory needs for banks and capital markets is expected to increase the technology spending by banks and other companies. As a result, there has been an increase in the demand of outsourcing services. Outsourcing services have high margins when compared to onshore services. This will help the company improve upon its revenue and margin because of the higher demand.

Cloud platform, analytics and mobile technology will help Accenture increase its revenue

According to the IDC, the market size of cloud computing will be around $98 billion by 2016. Accenture has invested around $400 million in the cloud platform. According to the company’s management of its cloud computing division, this investment has started giving returns. The revenue from the cloud computing platform was about $1 billion in fiscal year 2012. Going forward, we will see a rise in the revenue from this platform.

Analytics and mobile technology is another platform that is expected to surge in the coming year. With increased spending in this segment across the globe, we expect that Accenture Plc (NYSE:ACN)’s revenue will grow in the coming year.

U.S. immigration bill will help Accenture over its Indian peers

The U.S. immigration bill will help the company, which has its major workforce in the US only. Accenture will benefit from this bill as it has around 1370 H1-B workers among its 30,000 employees in the U.S. If the bill passes, it can increase the number of its H1-B visa holders without having to dole out extra to pay for H1-B visas. This will give Accenture Plc (NYSE:ACN) a competitive edge over the Indian IT players.

Increasing demand for large transformational projects will have an impact on short term revenue

There has been a change in the nature of the consultancy projects. The clients are now demanding larger transformational projects with longer durations. This has impacted the revenue stream in the short run. The company is expected to have a positive impact from this going forward. The short term consulting projects have remained flat and are expected to remain so in the coming quarters, so revenue from this will be stable.

Peer analysis

Infosys Ltd ADR (NYSE:INFY) has undergone a leadership change recently. It’s most charismatic and influential leader Narayan Murthy is back at Infosys as executive chairman. This has been necessitated due to Infosys Ltd ADR (NYSE:INFY)’s falling fortunes in the last two years. Narayan Murthy has come at a time when the company has fallen behind its peers. The Company will look up to Narayan Murthy’s experience and leadership skills to sail the company out of this turbulent phase.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!